Clinical experience over 48 years with pheochromocytoma

Area of Science:

• Endocrinology
• Oncology
• Surgical Pathology

Background:

• Controversies exist regarding pheochromocytoma malignancy rates, particularly for extraadrenal tumors.
• Limited statistical analysis and debate surround the predictive value of microscopic tumor features.

Purpose of the Study:

• To analyze the presentation, localization, surgical management, pathology, and long-term outcomes of a large cohort of pheochromocytoma patients.
• To compare the malignancy risk and survival rates between adrenal and extraadrenal pheochromocytomas.

Main Methods:

• Prospective follow-up of 104 patients (108 pheochromocytomas) from 1950 to 1998.
• Review of medical records for clinical, pathological, and surgical data.
• Kaplan-Meier survival analysis.

Main Results:

• No statistically significant difference in malignancy rates or survival between adrenal and extraadrenal pheochromocytomas.
• 46% of patients with extraadrenal tumors had malignant disease or features, with malignancy developing up to 15 years post-resection.
• Overall malignancy rate was 13% for adrenal and 23% for extraadrenal pheochromocytomas.

Conclusions:

• Extraadrenal pheochromocytomas carry similar malignancy risks and survival outcomes as adrenal counterparts.
• Lifelong patient follow-up is mandatory for effective management and monitoring.